-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Judges from the Shijiazhuang High-Tech Zone Court bring “legal education” services directly to enterprises.
Category:
Time：2020-04-23
On the morning of April 22, three judges from the People's Court of the Shijiazhuang High-Tech Industrial Development Zone visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct a survey and assess the legal service needs of the company during its resumption of production and operations.
On the morning of April 22, three judges from the People’s Court of the Shijiazhuang High-Tech Industrial Development Zone visited Shijiazhuang Sihua Pharmaceutical Co., Ltd. to conduct a survey and assess the legal service needs of the company during its resumption of production and operations.
At the high-tech zone factory, the judges went deep into the production workshops, gaining a detailed understanding of the manufacturing process for infusion preparations. They carefully inquired with Shi Jianhui, Secretary of the Party Committee of Shijiazhuang No. 4 Pharmaceutical Co., Ltd., and Wang Hongliang, Deputy General Manager of the operating company, about the company’s drug production and supply situation during epidemic prevention and control, as well as its contributions to the fight against the pandemic. The judges highly praised the company’s strong sense of social responsibility demonstrated in the face of this major public health crisis.
During the symposium, the judges carefully listened to the legal issues encountered by enterprises in their production and business operations. The judges stated that they would further leverage their official duties, promptly heed enterprises’ requests and suggestions, strengthen the delivery of legal services to the grassroots level, and strive to provide robust support for the development of enterprises in the high-tech zone.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license